• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Pregnancy and Postpartum Course
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » psychopharmacology_tips

Articles Tagged with ''psychopharmacology_tips''

Trauma Systems Therapy

May 1, 2015
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Learn about Trauma Systems Therapy (TST) and its use with young patients in an interview with Glenn Saxe, MD, Arnold Simon professor and chair, Department of Child and Adolescent Psychiatry, and director, the Child Study Center.
Read More

Informed Consent in Opioid Addiction Treatment: An Ethical Obligation

May 22, 2014
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Mark Willenbring, MD
Informed consent—whether it be for psychotherapy, prescribing a medication, or performing a surgical procedure—is an ethical principle firmly established in law and medicine. While there has been no formal research on this subject, my experience suggests that many addiction treatment programs fail to obtain valid informed consent.
Read More

Dealing With Side Effects of SSRIs

May 1, 2014
Pavan Madan, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Pavan Madan, MD
Selective serotonin reuptake inhibitors (SSRIs) are widely used as the first-line treatment for depression and anxiety in children and adolescents, but they are associated with significant adverse effects (AEs). Studies have shown that up to 50% of kids experience side effects from SSRIs, depending on the sample size and the type of study.
Read More

Metabolic and Extrapyramidal Effects of Antipsychotics

May 1, 2014
Tamara Pringsheim, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

CCPR-May2014_Pringsheim_headshot.png

Tamara Pringsheim, MD
Assistant Professor, Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences University of Calgary.
Dr. Pringsheim has disclosed that she has been a paid consultant to Teva Neuroscience, Allergan, and Shire Canada. The editors have reviewed this interview and found no evidence of bias in this educational activity.

Pharmacoepidemiologist Tamara Pringsheim, MD, describes strategies for dealing with metabolic, extrapyramidal, and hormonal side effects of antipsychotics.
Read More

Vivitrol: Another Option for Opioid Addiction?

May 1, 2014
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
David A. Frenz, MD
Naltrexone first hit the US market as an oral medication (ReVia) way back in 1984. Over the years, it developed a solid reputation for treating alcoholism and remains a first-line therapy today. Naltrexone was a bust, however, when it came to treating opioid addiction.
Read More

Methadone versus Buprenorphine

May 1, 2014
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Get insight into the differences between methadone and buprenorphine when used to treat opioid addiction, in an interview with Gavin Bart, MD, PhD, FACP, FASAM, director of the division of addiction medicine at Hennepin County Medical Center in Minnesota.
Read More

The Facts on Tardive Dyskinesia

April 1, 2014
Olga Waln, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Olga Waln, MD Neurologist, Houston Methodist Neurological Institute, Department of Neurology Dr. Waln has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
We’re all aware that neuroleptics and other dopamine-receptor blocking agents (DRBAs) can cause a variety of movement disorders, often referred to as extrapyramidal syndromes (EPS).
Read More

Medication Non-Adherence: The Make-It-or-Break-It of Psychopharmacology

December 1, 2013
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
John D. Preston, PsyD, ABPP
Both in general medicine and in psychiatry, the number one cause of treatment failure is not taking medications as prescribed. There are a number of reasons for non-adherence, ranging from physical side effects to psychological issues. Here, we’ll discuss the most common reasons for non-adherence, and some strategies for helping your patients stay on their meds.
Read More

Managing Side Effects of Psychotropics

June 1, 2013
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Alysia Cirona Singh, MD
We all know that medication use for psychiatric disorders in kids has been increasing over the past 10 years, and that it plays an important role in treatment. We also know that side effects can cause alarm among parents and young patients.
Read More

Drug Interactions in Child Psychiatry

June 1, 2013
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jessica L. Goren, PharmD, BCPP
Drug interactions are a common issue in psychopharmacology. The advent of drug interaction software has made it easier to keep track of drug interactions, but it is still important to have a sound understanding of the principles in order to apply the results of drug interaction software alerts to daily patient care.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.